ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Brief Therapy Intervention for Heavy/Hazardous Drinking in HIV-Positive Women

This study is currently recruiting participants.
Verified by National Institute on Alcohol Abuse and Alcoholism (NIAAA), September 2008

Sponsored by: National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Information provided by: National Institute on Alcohol Abuse and Alcoholism (NIAAA)
ClinicalTrials.gov Identifier: NCT00127231
  Purpose

The purpose of this study is to determine whether two brief counseling sessions reduce drinking and improve health outcomes in HIV-positive women who drink at heavy/hazardous levels.


Condition Intervention Phase
HIV Infections
Alcoholism
Behavioral: Brief alcohol intervention based on Project Treat
Behavioral: Standard care
Phase III

MedlinePlus related topics:   AIDS    Alcoholism   

ChemIDplus related topics:   Ethanol   

U.S. FDA Resources

Study Type:   Interventional
Study Design:   Treatment, Randomized, Open Label, Active Control, Single Group Assignment, Efficacy Study
Official Title:   Brief Alcohol Intervention in HIV+ Women

Further study details as provided by National Institute on Alcohol Abuse and Alcoholism (NIAAA):

Primary Outcome Measures:
  • Mean weekly drinking quantity/frequency [ Time Frame: Baseline through 1 year follow-up ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • HIV health outcomes [ Time Frame: baseline through 1 year follow-up ] [ Designated as safety issue: No ]
  • HIV treatment adherence [ Time Frame: baseline through 1 year follow-up ] [ Designated as safety issue: No ]

Estimated Enrollment:   200
Study Start Date:   September 2007
Estimated Study Completion Date:   September 2009
Estimated Primary Completion Date:   September 2009 (Final data collection date for primary outcome measure)

Arms Assigned Interventions
1 Brief Intervention: Experimental
The brief intervention will include two sessions that review drinking patterns and behavior change strategies as well as two telephone calls to reinforce session content.
Behavioral: Brief alcohol intervention based on Project Treat
The brief intervention will include two sessions that review drinking patterns and behavior change strategies as well as two telephone calls to reinforce session content.
2 Standard Care Arm: Active Comparator Behavioral: Standard care
Hazardous/binge female drinkers will be identified in the Johns Hopkins Hospital HIV clinic and will be randomized to brief intervention or standard care. Outcome measures will include: alcohol/drug use, engagement in an on-site alcohol support group and other substance abuse treatment services, HIV-risk behaviors, HIV disease markers and treatment compliance, and psychiatric symptoms.

Detailed Description:

Heavy alcohol use negatively impacts HIV/AIDS in several important ways. It increases HIV-risk behaviors, impairs the immune system and accelerates HIV disease progression. Heavy alcohol use also interferes with HIV care compliance, including appointment attendance and medication adherence.

Women are particularly important targets for alcohol use interventions. The threshold for harmful alcohol effects is strikingly low in women, with two drinks per day placing women at risk for negative health consequences. Heavy/hazardous alcohol use is less likely to be detected in women receiving health services. Women may be less likely to seek and or engage in alcohol treatment services, making nontraditional care settings particularly important for reaching this population.

This proposal tests the utility of a brief alcohol intervention for HIV+ women delivered in a medical setting. Hazardous/binge female drinkers will be identified in the Johns Hopkins Hospital HIV clinic and will be randomized to brief intervention or standard care. The brief intervention will include two sessions that review drinking patterns and behavior change strategies as well as two telephone calls to reinforce session content. Outcome measures will include: alcohol/drug use, engagement in an on-site alcohol support group and other substance abuse treatment services, HIV-risk behaviors, HIV disease markers and treatment compliance, and psychiatric symptoms.

The investigators hypothesize that women who receive the brief intervention will report lower mean weekly alcohol consumption and fewer heavy drinking episodes than women in standard care. The investigators also predict that women who receive brief intervention will adhere to their HIV medications and keep their health care appointments more consistently, and have improved HIV-related health outcomes.

Comparison(s): Standard HIV care

  Eligibility
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No

Criteria

Inclusion Criteria:

  • Heavy/hazardous drinking levels (i.e., consuming 8 or more drinks per week, or have reported at least two heavy drinking occasions [4 or more drinks/drinking episode] in the last six months, or score positively on the CAGE or T-ACE).
  • HIV-positive
  • Receiving HIV care in Johns Hopkins Hospital (JHH) Moore Clinic

Exclusion Criteria:

  • Actively psychotic and other severe mental health symptoms
  • Current enrollment in alcohol or drug treatment
  • Current enrollment in Hopkins psychiatric services
  • Pregnancy (because of the ethical concern of randomization to standard care)
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00127231

Contacts
Contact: Mary E. McCaul, Ph.D.     410-955-5439     mmccaul1@jhmi.edu    

Locations
United States, Maryland
Johns Hopkins Hospital     Recruiting
      Baltimore, Maryland, United States, 21205
      Contact: Mary E. McCaul, Ph.D.     410-955-5439     mmccaul1@jhmi.edu    

Sponsors and Collaborators

Investigators
Principal Investigator:     Mary E. McCaul, Ph.D.     Johns Hopkins University    
  More Information


Responsible Party:   Johns Hopkins University School of Medicine ( Mary E. McCaul, Ph.D. )
Study ID Numbers:   NIAAAMCC014500, R01-AA014500
First Received:   August 3, 2005
Last Updated:   September 16, 2008
ClinicalTrials.gov Identifier:   NCT00127231
Health Authority:   United States: Federal Government

Keywords provided by National Institute on Alcohol Abuse and Alcoholism (NIAAA):
Controlled Clinical Trials, Randomized  
Alcohol Consumption  
Behavioral Research  
HIV
Alcohol Abuse
Alcohol Consumption

Study placed in the following topic categories:
Sexually Transmitted Diseases, Viral
Acquired Immunodeficiency Syndrome
Disorders of Environmental Origin
Alcohol Drinking
Immunologic Deficiency Syndromes
Virus Diseases
HIV Seropositivity
Mental Disorders
HIV Infections
Alcoholism
Sexually Transmitted Diseases
Substance-Related Disorders
Alcohol-Related Disorders
Retroviridae Infections
Ethanol

Additional relevant MeSH terms:
Anti-Infective Agents
Anti-Infective Agents, Local
RNA Virus Infections
Slow Virus Diseases
Immune System Diseases
Therapeutic Uses
Physiological Effects of Drugs
Lentivirus Infections
Central Nervous System Depressants
Infection
Central Nervous System Agents
Pharmacologic Actions

ClinicalTrials.gov processed this record on October 10, 2008




Links to all studies - primarily for crawlers